About 2-amino-5-(3-bromophenyl)-5-(2,6-dimethyl-4-pyridinyl)-3-methylimidazol-4-one
2-amino-5-(3-bromophenyl)-5-(2,6-dimethyl-4-pyridinyl)-3-methylimidazol-4-one (PubChem CID 59834572) has the molecular formula C17H17BrN4O
and a molecular weight of 373.25 g/mol. Its IUPAC name is 2-amino-5-(3-bromophenyl)-5-(2,6-dimethyl-4-pyridinyl)-3-methylimidazol-4-one.
Analyze 2-amino-5-(3-bromophenyl)-5-(2,6-dimethyl-4-pyridinyl)-3-methylimidazol-4-one with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 2-amino-5-(3-bromophenyl)-5-(2,6-dimethyl-4-pyridinyl)-3-methylimidazol-4-one?
The IUPAC name of 2-amino-5-(3-bromophenyl)-5-(2,6-dimethyl-4-pyridinyl)-3-methylimidazol-4-one (CID 59834572) is 2-amino-5-(3-bromophenyl)-5-(2,6-dimethyl-4-pyridinyl)-3-methylimidazol-4-one.
What is the SMILES notation for 2-amino-5-(3-bromophenyl)-5-(2,6-dimethyl-4-pyridinyl)-3-methylimidazol-4-one?
The canonical SMILES for 2-amino-5-(3-bromophenyl)-5-(2,6-dimethyl-4-pyridinyl)-3-methylimidazol-4-one is Cc1cc(C2(c3cccc(Br)c3)N=C(N)N(C)C2=O)cc(C)n1.
What is the InChIKey of 2-amino-5-(3-bromophenyl)-5-(2,6-dimethyl-4-pyridinyl)-3-methylimidazol-4-one?
The InChIKey is ARCXTDNNCWVNDH-UHFFFAOYSA-N. The full InChI is InChI=1S/C17H17BrN4O/c1-10-7-13(8-11(2)20-10)17(12-5-4-6-14(18)9-12)15(23)22(3)16(19)21-17/h4-9H,1-3H3,(H2,19,21).
What are the key properties of 2-amino-5-(3-bromophenyl)-5-(2,6-dimethyl-4-pyridinyl)-3-methylimidazol-4-one?
2-amino-5-(3-bromophenyl)-5-(2,6-dimethyl-4-pyridinyl)-3-methylimidazol-4-one has a molecular weight of 373.25 g/mol, XLogP of 2.49, 2 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 2-amino-5-(3-bromophenyl)-5-(2,6-dimethyl-4-pyridinyl)-3-methylimidazol-4-one is sourced from PubChem (CID 59834572), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).